Analystreport

Crescent Biopharma (NASDAQ:CBIO) is now covered by analysts at Weiss Ratings. They set a "sell (e-)" rating on the stock.

Crescent Biopharma, Inc.  (CBIO) 
Last crescent biopharma, inc. earnings: 11/7 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: catalystbiosciences.com/investors